Richard S. Camplejohn

3.7k total citations · 1 hit paper
62 papers, 3.1k citations indexed

About

Richard S. Camplejohn is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Richard S. Camplejohn has authored 62 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 26 papers in Molecular Biology and 18 papers in Cancer Research. Recurrent topics in Richard S. Camplejohn's work include Cancer Genomics and Diagnostics (9 papers), Cancer-related Molecular Pathways (9 papers) and Lymphoma Diagnosis and Treatment (8 papers). Richard S. Camplejohn is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Cancer-related Molecular Pathways (9 papers) and Lymphoma Diagnosis and Treatment (8 papers). Richard S. Camplejohn collaborates with scholars based in United Kingdom, United States and Spain. Richard S. Camplejohn's co-authors include Cheryl Gillett, David P. Lane, D M Barnes, R. Dover, Amanda L. Woods, Peter A. Hall, C. C.‐W. Yu, Johnathan Watkins, Naushin Waseem and David A. Levison and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Richard S. Camplejohn

62 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms

1990 1.3k citations Peter A. Hall, David A. Levison et al. The Journal of Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard S. Camplejohn United Kingdom	26	1.1k	1.0k	736	582	514	62	3.1k
W. Böcker Germany	38	1.3k 1.2×	1.8k 1.7×	576 0.8×	890 1.5×	753 1.5×	183	4.7k
Kalle Alanen Finland	34	1.5k 1.4×	1.5k 1.4×	942 1.3×	754 1.3×	315 0.6×	98	3.8k
Kouki Inai Japan	32	868 0.8×	1.2k 1.2×	1.0k 1.4×	457 0.8×	215 0.4×	104	3.1k
Yoh Dobashi Japan	33	1.5k 1.5×	1.5k 1.5×	1.2k 1.6×	434 0.7×	426 0.8×	105	3.6k
A. Julian Garvin United States	32	733 0.7×	2.2k 2.1×	1.2k 1.6×	327 0.6×	822 1.6×	80	4.0k
Libero Lauriola Italy	39	637 0.6×	1.1k 1.0×	496 0.7×	473 0.8×	212 0.4×	179	4.3k
Silke Brüderlein Germany	30	870 0.8×	1.5k 1.4×	583 0.8×	532 0.9×	711 1.4×	65	3.5k
D M Barnes United Kingdom	26	2.3k 2.2×	2.0k 1.9×	680 0.9×	958 1.6×	593 1.2×	41	4.3k
Feliciano Baldi Italy	34	1.0k 1.0×	1.5k 1.4×	514 0.7×	361 0.6×	359 0.7×	76	3.4k
Ester Piek Netherlands	27	998 0.9×	3.3k 3.2×	401 0.5×	491 0.8×	391 0.8×	42	4.6k

Countries citing papers authored by Richard S. Camplejohn

Since Specialization

Citations

This map shows the geographic impact of Richard S. Camplejohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard S. Camplejohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard S. Camplejohn more than expected).

Fields of papers citing papers by Richard S. Camplejohn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard S. Camplejohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard S. Camplejohn. The network helps show where Richard S. Camplejohn may publish in the future.

Co-authorship network of co-authors of Richard S. Camplejohn

This figure shows the co-authorship network connecting the top 25 collaborators of Richard S. Camplejohn. A scholar is included among the top collaborators of Richard S. Camplejohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard S. Camplejohn. Richard S. Camplejohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barwell, Julian, Laurent Pangon, Shirley Hodgson, et al.. (2007). Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics. Journal of Medical Genetics. 44(8). 516–520. 15 indexed citations

Docherty, Zoe, Caroline Langman, Ian Kesterton, et al.. (2006). Is chromosome radiosensitivity and apoptotic response to irradiation correlated with cancer susceptibility?. International Journal of Radiation Biology. 83(1). 1–12. 19 indexed citations

Camplejohn, Richard S., Ian R. Hart, Robert W. Wilkinson, et al.. (2004). Oral Presentations 5. British Journal of Cancer. 91(S1). S16–S17. 1 indexed citations

Zhu, Gang, R Gilchrist, Mark R. Morgan, et al.. (2004). Reduction of TSG101 protein has a negative impact on tumor cell growth. International Journal of Cancer. 109(4). 541–547. 48 indexed citations

Camplejohn, Richard S.. (2003). Flow Cytometric Measurement of Cell Proliferation. Humana Press eBooks. 57. 133–143. 3 indexed citations

Camplejohn, Richard S., R Gilchrist, Douglas F. Easton, et al.. (2003). Apoptosis, ageing and cancer susceptibility. British Journal of Cancer. 88(4). 487–490. 31 indexed citations

Rutherford, Julian C., Carol Chu, Ruth Charlton, et al.. (2002). Investigations on a clinically and functionally unusual and novel germline p53 mutation. British Journal of Cancer. 86(10). 1592–1596. 16 indexed citations

Lynch, Jill E., D M Barnes, A M Hanby, et al.. (2002). Mitotic counts provide additional prognostic information in grade II mammary carcinoma. The Journal of Pathology. 196(3). 275–279. 11 indexed citations

Salud, Antonieta, et al.. (1999). Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer. Journal of Surgical Oncology. 72(3). 167–174. 30 indexed citations

10.

Vile, Richard G., Simon Castleden, John F. Marshall, et al.. (1997). Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression. International Journal of Cancer. 71(2). 267–274. 165 indexed citations

11.

Barnes, D M & Richard S. Camplejohn. (1996). P53, apoptosis, and breast cancer. Journal of Mammary Gland Biology and Neoplasia. 1(2). 163–175. 34 indexed citations

12.

Mentzel, Thomas, Eduardo Calonje, Catherine Wadden, et al.. (1996). Myxofibrosarcoma. The American Journal of Surgical Pathology. 20(4). 391–405. 361 indexed citations

13.

Brooks, Susan A., Anthony J. Leathem, Richard S. Camplejohn, & Walter M. Gregory. (1993). Markers of prognosis in breast cancer - the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy. Breast Cancer Research and Treatment. 25(3). 247–256. 20 indexed citations

14.

Wilson, George D., et al.. (1992). Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10. European Journal of Cancer. 28(12). 2010–2017. 24 indexed citations

15.

O'Reilly, S.M., R.D. Rubens, M A Richards, & Richard S. Camplejohn. (1992). DNA flow cytometry and response to preoperative chemotherapy for primary breast cancer. European Journal of Cancer. 28(2-3). 681–683. 60 indexed citations

16.

O'Reilly, S.M., Richard S. Camplejohn, Rosemary R. Millis, R.D. Rubens, & Michael A. Richards. (1990). Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancer. European Journal of Cancer and Clinical Oncology. 26(10). 1035–1038. 31 indexed citations

17.

Hall, Peter A., David A. Levison, Amanda L. Woods, et al.. (1990). Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms. The Journal of Pathology. 162(4). 285–294. 1299 indexed citations breakdown →

18.

Macartney, J. C., et al.. (1989). DNA flow cytometry of thymomas. Histopathology. 15(1). 77–83. 12 indexed citations

19.

Masters, John R., Richard S. Camplejohn, M C Parkinson, & C.R.J. Woodhouse. (1989). DNA Ploidy and the Prognosis of Stage pT1 Bladder Cancer. British Journal of Urology. 64(4). 403–408. 19 indexed citations

20.

Wright, Nicholas A. & Richard S. Camplejohn. (1983). Psoriasis, cell proliferation. Churchill Livingstone eBooks. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact